Advanced search×

The temporal requirement for vitamin A in the developing eye: Mechanism of action in optic fissure closure and new roles for the vitamin in regulating cell proliferation and adhesion in the embryonic retina

Dev Biol 325(1):12 (2009) PMID 18955041

Mammalian eye development requires vitamin A (retinol, ROL). The role of vitamin A at specific times during eye development was studied in rat fetuses made vitamin A deficient (VAD) after embryonic day (E) 10.5 (late VAD). The optic fissure does not close in late VAD embryos, and severe folding and collapse of the retina is observed at E18.5. Pitx2, a gene required for normal optic fissure closure, is dramatically downregulated in the periocular mesenchyme in late VAD embryos, and dissolution of the basal lamina does not occur at the optic fissure margin. The addition of ROL to late VAD embryos by E12.5 restores Pitx2 expression, supports dissolution of the basal lamina, and prevents coloboma, whereas supplementation at E13.5 does not. Surprisingly, ROL given as late as E13.5 completely prevents folding of the retina despite the presence of an open fetal fissure, showing that coloboma and retinal folding represent distinct VAD-dependent defects. Retinal folding due to VAD is preceded by an overall reduction in the percentage of cyclin D1 positive cells in the developing retina, (initially resulting in retinal thinning), as well as a dramatic reduction in the cell adhesion-related molecules, N-cadherin and @b-catenin. Reduction of retinal cell number combined with a loss of the normal cell-cell adhesion proteins may contribute to the collapse and folding of the retina that occurs in late VAD fetuses.

Copyright © 2009 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ydbio.2008.09.030
Version: za2963e q8za3 q8zb8 q8zc9 q8zd9 q8zec q8zfc q8zgb

Similar articles you may find interesting…

  1. Use of new oral anticoagulants in antiphospholipid syndrome.

    Curr Rheumatol Rep 15(6):331 (2013) PMID 23649961

    We discuss clinical and laboratory aspects of NOAC. These agents have been approved for several therapeutic indications based on phase III prospective randomised controlled clinical trials using warfarin at a target INR of 2.5 (i.e. range 2.0-3.0) as the comparator. However these trials may not be d...
  2. Time-Resolved Fluorescence Studies of Fullerene Derivatives.

    J Phys Chem B (2013) PMID 23646878

    We have developed a time-correlated single-photon counting apparatus with which we were not only able to detect the fluorescence of fullerene and its derivatives in water, but could also measure fluorescence temporal decays and determine lifetimes in the range of tens of picoseconds. The compounds s...
  3. Development of Contrast-Induced Nephropathy in Subarachnoid Hemorrhage: a Single Center Perspective.

    Neurocrit Care (2013) PMID 23653268

    The incidence of CIN in SAH patients is comparable to previously published reports on non-neurological cohorts. No definite association was noted with any predisposing factors postulated to be responsible for CIN, except for advanced age. Concurrent use of 3 % HTS was not associated with CIN in thi...